Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia

World Journal of Gastroenterology

Volumn 17, Issue 21, 2011, Pages 2646-2651

  Chojnacki, Cezary ^a   Poplawski, Tomasz ^b   Klupinska, Grazyna ^a   Blasiak, Janusz ^b   Chojnacki, Jan ^a   Reiter, Russel J ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c University of Texas Health Science Center   (United States)

Author keywords

6 sulfatoxymelatonin; Epigastric pain syndrome; Functional dyspepsia; Melatonin; Postprandial distress syndrome

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

6 HYDROXYMELATONIN O SULFATE URINARY EXCRETION; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC PAIN SYNDROME; FEMALE; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL DISEASE; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELATONIN URINARY EXCRETION; POSTPRANDIAL DISTRESS SYNDROME; URINALYSIS; URINE LEVEL;

EID: 79958049202     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i21.2646     Document Type: Article

References (41)

1. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10: 350-366
2. Messner M, Huether G, Lorf T, Ramadori G, Schwörer H. Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci 2001; 69: 543-551
3. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50: 1129-1146
4. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Bandyopadhyay D. Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. J Physiol Pharmacol 2003; 54 Suppl 4: 113-125
5. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126
6. Cabeza J, Alarcón-de-la-Lastra C, Jiménez D, Martín MJ, Motilva V. Melatonin modulates the effects of gastric injury in rats: role of prostaglandins and nitric oxide. Neurosignals 2003; 12: 71-77
7. Sjöblom M, Flemström G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34: 288-293
8. Jaworek J, Brzozowski T, Konturek SJ. Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res 2005; 38: 73-83
9. Kato K, Murai I, Asai S, Takahashi Y, Matsuno Y, Komuro S, Kurosaka H, Iwasaki A, Ishikawa K, Arakawa Y. Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 1998; 9: 3989-3992
10. Kasimay O, Cakir B, Devseren E, Yegen BC. Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol 2005; 56: 543-553
11. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200
12. Lahiri S, Singh P, Singh S, Rasheed N, Palit G, Pant KK. Melatonin protects against experimental reflux esophagitis. J Pineal Res 2009; 46: 207-213
13. Konturek PC, Konturek SJ, Brzozowski T, Dembinski A, Zembala M, Mytar B, Hahn EG. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stressinduced and ischaemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32: 433-438
14. Konturek SJ, Brzozowski T, Konturek PC, Zwirska-Korczala K, Reiter RJ. Day/night differences in stress-induced gastric lesions in rats with an intact pineal gland or after pinealectomy. J Pineal Res 2008; 44: 408-415
15. Sener-Muratoǧlu G, Paskaloǧlu K, Arbak S, Hürdaǧ C, Ayanoǧlu-Dülger G. Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats. Dig Dis Sci 2001; 46: 318-330
16. Bandyopadhyay D, Bandyopadhyay A, Das PK, Reiter RJ. Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage. J Pineal Res 2002; 33: 1-7
17. Malinovskaya N, Komarov FI, Rapoport SI, Voznesenskaya LA, Wetterberg L. Melatonin production in patients with duodenal ulcer. Neuro Endocrinol Lett 2001; 22: 109-117
18. Komarov FI, Rapoport SI, Malinovskaia NK, Voznesenskaia LA, Sharov AA, Vetterberg L. [Melatonin production in patients with duodenal ulcer at different stages of disease]. Klin Med (Mosk) 1998; 76: 15-18
19. Komarov FI, Rappoport SI, Malinovskaia NK, Voznesenskaia LA, Vetterberg L. [Melatonin: ulcer disease and seasons of the year]. Klin Med (Mosk) 2003; 81: 17-21
20. Klupińska G, Wiśniewska-Jarosińska M, Harasiuk A, Chojnacki C, Stec-Michalska K, Błasiak J, Reiter RJ, Chojnacki J. Nocturnal secretion of melatonin in patients with upper digestive tract disorders. J Physiol Pharmacol 2006; 57 Suppl 5: 41-50
21. Klupińska G, Harasiuk A, Popławski T, Chojnacki C, Blasiak J, Chojnacki J. Nocturnal secretion of melatonin in patients with functional dyspepsia. Gastroenterol Pol 2007; 14: 103-106
22. Klupińska G, Poplawski T, Drzewoski J, Harasiuk A, Reiter RJ, Blasiak J, Chojnacki J. Therapeutic effect of melatonin in patients with functional dyspepsia. J Clin Gastroenterol 2007; 41: 270-4
23. Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997; 6: 40-44
24. Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sliwowski Z, Cześnikiewicz-Guzik M, Kwiecień S, Brzozowski T, Bubenik GA, Pawlik WW. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 2007; 58: 381-405
25. Baskett JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 1998; 24: 58-61
26. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985; 60: 1166-1173
27. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, Ferrer J, de la Rosa A, Vargas M, Reiter RJ. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26: 89-93
28. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110
29. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008; 45: 235-246
30. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200
31. Luboshitzky R, Herer P, Shen-Orr Z. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment. Exp Clin Endocrinol Diabetes 2004; 112: 102-107
32. Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med 1995; 123: 274-277
33. Tortosa F, Puig-Domingo M, Peinado MA, Oriola J, Webb SM, de Leiva A. Enhanced circadian rhythm of melatonin in anorexia nervosa. Acta Endocrinol (Copenh) 1989; 120: 574-578
34. Rapoport SI, Raǐkhlin NT, Malinovskaia NK, Lakshin AA. [Ultrastructural changes in cells of the antral gastric mucosa in patients with duodenal ulcers treated with melatonin]. Ter Arkh 2003; 75: 10-14
35. Konturek PC, Celinski K, Slomka M, Cichoz-Lach H, Burnat G, Naegel A, Bielanski W, Konturek JW, Konturek SJ. Melatonin and its precursor L-tryptophan prevent acute gastric mucosal damage induced by aspirin in humans. J Physiol Pharmacol 2008; 59 Suppl 2: 67-75
36. Wasdell MB, Jan JE, Bomben MM, Freeman RD, Rietveld WJ, Tai J, Hamilton D, Weiss MD. A randomized, placebocontrolled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008; 44: 57-64
37. Maldonado MD, Reiter RJ, Pérez-San-Gregorio MA. Melatonin as a potential therapeutic agent in psychiatric illness. Hum Psychopharmacol 2009; 24: 391-400
38. Bubenik GA. The effect of serotonin, N-acetylserotonin, and melatonin on spontaneous contractions of isolated rat intestine. J Pineal Res 1986; 3: 41-54
39. Reyes-Vázquez C, Naranjo-Rodríguez EB, García-Segoviano JA, Trujillo-Santana JT, Prieto-Gómez B. Apamin blocks the direct relaxant effect of melatonin on rat ileal smooth muscle. J Pineal Res 1997; 22: 1-8
40. Forster ER, Green T, Elliot M, Bremner A, Dockray GJ. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990; 258: G552-G556
41. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005; 22: 927-934